Langerhans cells are not required for graft-versus-host disease
Open Access
- 13 January 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 117 (2), 697-707
- https://doi.org/10.1182/blood-2010-07-299073
Abstract
Graft-versus-host disease (GVHD) is initiated and maintained by antigen-presenting cells (APCs) that prime alloreactive donor T cells. APCs are therefore attractive targets for GVHD prevention and treatment. APCs are diverse in phenotype and function, making understanding how APC subsets contribute to GVHD necessary for the development of APC-targeted therapies. Langerhans cells (LCs) have been shown to be sufficient to initiate skin GVHD in a major histocompatibility complex–mismatched model; however, their role when other host APC subsets are intact is unknown. To address this question, we used mice genetically engineered to be deficient in LCs by virtue of expression of diphtheria toxin A under the control of a BAC (bacterial artificial chromosome) transgenic hu-man Langerin locus. Neither CD8- nor CD4-mediated GVHD was diminished in recipients lacking LCs. Similarly, CD8- and CD4-mediated GVHD, including that in the skin, was unaffected if bone marrow came from donors that could not generate LCs, even though donor LCs engrafted in control mice. Engraftment of donor LCs after irradiation in wild-type hosts required donor T cells, with immunofluorescence revealing patches of donor and residual host LCs. Surprisingly, donor LC engraftment in Langerin-diphtheria toxin A (DTA) transgenic hosts was independent of donor T cells, suggesting that a Langerin+ cell regulates repopulation of the LC compartment.Keywords
This publication has 53 references indexed in Scilit:
- The evolving function of Langerhans cells in adaptive skin immunityImmunology & Cell Biology, 2010
- Development of Monocytes, Macrophages, and Dendritic CellsScience, 2010
- CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cellsThe Journal of Experimental Medicine, 2009
- Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC networkThe Journal of Experimental Medicine, 2009
- Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodesThe Journal of Experimental Medicine, 2008
- Langerhans Cells Are Not Required for Efficient Skin Graft RejectionJournal of Investigative Dermatology, 2008
- Identification of a novel population of Langerin+ dendritic cellsThe Journal of Experimental Medicine, 2007
- The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cellsThe Journal of Experimental Medicine, 2007
- Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cellsThe Journal of Experimental Medicine, 2007
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002